Tag Archive for: LegoChem Biosciences

partnership

SOTIO licences first cancer ADC from LegoChem Biosciences

SOTIO Biotech a.s. has exercised its first of five exclusive, target-specific options for antibody-drug conjugate (ADC) SOT106 under its agreement with LegoChem Biosciences Inc.

Read more